Bi-allelic SPATA22 variants cause premature ovarian insufficiency and nonobstructive azoospermia due to meiotic arrest

Clin Genet. 2022 May;101(5-6):507-516. doi: 10.1111/cge.14129. Epub 2022 Mar 16.

Abstract

The genetic causes of idiopathic premature ovarian insufficiency (POI) and nonobstructive azoospermia (NOA) remain unclear. We performed whole-exome sequencing (WES) in members of a consanguineous family with two POI and two NOA patients to screen for potential pathogenic variants for familial POI and NOA. And a homozygous variant in SPATA22 (c.400C>T:p.R134X) was identified. Histological analysis and spermatocyte spreading assay demonstrated that the spermatogenesis was arrested at a zygotene-like stage in the proband with NOA. The candidate gene was further screened in the in-house WES database of idiopathic POI-affected patients. One additional compound heterozygous variant in SPATA22 (c.900+1G>A and c.31C>T:p.R11X) was found in one patient with sporadic POI and validated by minigene assay. Thus, this is the first report identifying SPATA22 as the causative gene for human POI. Combined with the observations in the familial patient with NOA, our findings highlighted the essential role of meiotic HR genes in gametogenesis and gonadal function maintenance.

Keywords: NOA; POI; SPATA22; gene variants; meiosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azoospermia* / genetics
  • Azoospermia* / pathology
  • Cell Cycle Proteins / genetics
  • Exome Sequencing
  • Female
  • Humans
  • Male
  • Primary Ovarian Insufficiency* / genetics

Substances

  • Cell Cycle Proteins
  • SPATA22 protein, human

Supplementary concepts

  • Azoospermia, Nonobstructive